Senores Pharmaceutical is a pharmaceutical company that develops and manufactures a wide range of pharmaceutical products, predominantly in the US, Canada, and UK. The company has a strong R&D capability to identify specialty and complex molecules to manufacture a portfolio of differentiated pharmaceutical products across therapeutic domains and dosage forms.
Senores Pharmaceuticals IPO open date is December 20, 2024 and the IPO will close on December 24, 2024. The company to raise around ₹582.11 crores via IPO that comprises fresh issue of ₹500 crores and offer for sale up to 21,00,000 equity shares with face value of ₹10 each.
Senores Pharmaceuticals IPO price band is ₹372 to ₹391 per share. The allotment of Senores Pharmaceuticals IPO date is December 26, 2024. The company reported revenue of ₹217.34 crores in 2024 against ₹39.02 crore in 2023. The company reported loss of ₹32.71 crores in 2024 against Profit of ₹8.43 crores in 2023.
Senores Pharmaceuticals IPO Details
| IPO Open Date: | December 20, 2024 |
| IPO Close Date: | December 24, 2024 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹372 to ₹391 Per Share |
| Issue Size: | Approx ₹582.11 Crores, 1,48,87,723 Equity Shares |
| Fresh Issue: | Approx ₹500 Crores, 1,27,87,723 Equity Shares |
| Offer for Sale: | Approx ₹82.11 Crores, 1,27,87,723 Equity Shares |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 10% |
| QIB Quota: | Not more than 75% |
| NII Quota: | Not more than 15% |
Senores Pharmaceuticals IPO Timeline
The Senores Pharmaceuticals IPO date is December 20 and the close date is December 24. The Senores Pharmaceuticals IPO allotment will be finalized on December 26 and the IPO listing on December 30.
| IPO Open Date: | December 20, 2024 |
| IPO Close Date: | December 24, 2024 |
| Basis of Allotment: | December 26, 2024 |
| Refunds: | December 27, 2024 |
| Credit to Demat Account: | December 27, 2024 |
| IPO Listing Date: | December 30, 2024 |
Senores Pharmaceuticals IPO Lots
| IPO Activity | Date |
|---|---|
| Issue Price | ₹372.00-391.00 |
| Market Lot: | 38 Shares |
| 1 Lot Amount: | ₹14858 |
| Min Small HNI Lots(2-10 Lakh): | 532 shares (14 lots) – ₹208012 |
| Min Big HNI Lots(10+ Lakh): | 2584 shares (68 lots) – ₹1010344 |
Senores Pharmaceuticals Limited Financial Performance Explained
Senores Pharmaceuticals Limited’s revenue increased by 457% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 678.08 | 621.88 | 131.05 | 59.15 |
| Revenue | 183.35 | 217.34 | 39.02 | 14.63 |
| Profit After Tax | 23.94 | 32.71 | 8.43 | 0.99 |
| Net Worth | 319.06 | 231.71 | 45.5 | 36.59 |
| Reserves and Surplus | 263.36 | 175.94 | 35.25 | 25.37 |
| Total Borrowing | 242.03 | 248.38 | 60.76 | 14.21 |
